Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidaseFrancesco Puzzo, Federico Mingozzi, Christian Leborgne et al.|Science Translational Medicine|2017Cited by 133
Exposure to wild-type AAV drives distinct capsid immunity profiles in humansKlaudia Kuranda, Federico Mingozzi, Priscilla Jean-Alphonse et al.|Journal of Clinical Investigation|2018Cited by 103
Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in MuscleJérôme Poupiot, Giuseppe Ronzitti, Helena Costa Verdera et al.|Molecular Therapy — Methods & Clinical Development|2019Cited by 21
Whole-body rescue of Pompe disease with AAV liver delivery of engineered secretable GAA transgenesPasqualina Colella, Federico Mingozzi, Francesco Puzzo et al.|Neuromuscular Disorders|2017Cited by 1
Interim Analysis of Immunogenicity to the Vector Capsid and Transgene-Expressed Human FVIII in a Phase-1/2 Clinical Study of Bmn 270, an AAV5-Mediated Gene Therapy for Hemophilia aBrian Long, Becky Schweighardt, Benjamin Kim et al.|Blood|2017Cited by 1